T‐cell epitope‐containing hypoallergenic β‐lactoglobulin for oral immunotherapy in milk allergy

H. Ueno,Teruhiko Kato,H. Ohnishi,N. Kawamoto,Zenichiro Kato,H. Kaneko,N. Kondo,Taku Nakano
DOI: https://doi.org/10.1111/pai.12642
2016-12-01
Pediatric Allergy and Immunology
Abstract:Optimally hydrolyzed β‐Lactoglobulin (βLg) is a promising milk oral immunotherapy (OIT) candidate with respect to showing reduced B‐cell reactivity but retaining the T‐cell epitope. To demonstrate that an edible hypoallergenic βLg hydrolysate containing the T‐cell epitope is suitable for OIT. We tested how chymotrypsin affected the retention of the T‐cell epitope of βLg when preparing βLg hydrolysates using food‐grade trypsin.
What problem does this paper attempt to address?